Observational studyArthritis research & therapy2023

Improvement in patient-reported outcomes and work productivity following 3-year ustekinumab or tumour necrosis factor inhibitor treatment in patients with psoriatic arthritis: results from the PsABio real-world study.

Laure Gossec et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.